Immutep Limited

Immutep Limitedverified

IMM.AX

Price:

$0.342

Market Cap:

$503.40M

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemo-immunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-003, which is in a Phase I clinical trial for the ...[Read more]

Industry

Biotechnology

IPO Date

1988-06-30

Stock Exchange

ASX

Ticker

IMM.AX

The Enterprise Value as of December 2025 (TTM) for Immutep Limited (IMM.AX) is 437.61M

According to Immutep Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 437.61M. This represents a change of 40.67% compared to the average of 311.09M of the last 4 quarters.

Immutep Limited (IMM.AX) Historical Enterprise Value (quarterly & annually)

How has IMM.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Immutep Limited over the last ten years is 152.64M. The current 437.61M Enterprise Value has changed 28.57% with respect to the historical average. Over the past ten years (40 quarters), IMM.AX's Enterprise Value was at its highest in in the June 2009 quarter at 631.08M. The Enterprise Value was at its lowest in in the December 2007 quarter at 0.

Quarterly (TTM)
Annual

Average

152.64M

Median

140.89M

Minimum

44.49M

Maximum

283.61M

Immutep Limited (IMM.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immutep Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 468.50%

Maximum Annual Enterprise Value = 283.61M

Minimum Annual Increase = -50.58%

Minimum Annual Enterprise Value = 44.49M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025283.61M33.92%
2024211.77M56.45%
2023135.36M-10.68%
2022151.55M-40.08%
2021252.93M468.50%
202044.49M-50.58%
201990.02M-14.96%
2018105.86M1.44%
2017104.36M-28.72%
2016146.41M-40.02%

Immutep Limited (IMM.AX) Average Enterprise Value

How has IMM.AX Enterprise Value performed in the past?

The current Enterprise Value of Immutep Limited (IMM.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

210.25M

5-year avg

207.05M

10-year avg

152.64M

Immutep Limited (IMM.AX) Enterprise Value vs. Peers

How is IMM.AX’s Enterprise Value compared to its peers?

Immutep Limited’s Enterprise Value is greater than Mayne Pharma Group Limited (241.42M), greater than Botanix Pharmaceuticals Limited (152.81M), greater than Dimerix Limited (277.04M), greater than Imricor Medical Systems, Inc. (199.71M), less than Artrya Limited (440.31M), greater than Orthocell Limited (236.63M), greater than Clinuvel Pharmaceuticals Limited (423.53M), greater than Paradigm Biopharmaceuticals Limited (113.33M), greater than EBR Systems, Inc. (279.87M), less than Race Oncology Limited (448.20M),

Build a custom stock screener for Immutep Limited (IMM.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (IMM.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Immutep Limited's Enterprise Value?

What is the highest Enterprise Value for Immutep Limited (IMM.AX)?

What is the 3-year average Enterprise Value for Immutep Limited (IMM.AX)?

What is the 5-year average Enterprise Value for Immutep Limited (IMM.AX)?

How does the current Enterprise Value for Immutep Limited (IMM.AX) compare to its historical average?